소피아 제네틱스 (SOPH) 주가

소피아 제네틱스(SOPH)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $8.19 (-3.99%), 시가총액 $0.34B, 52주 최저~최고 $2.85 ~ $5.52.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company was incorporated in 2011 and is based in Rolle, Switzerland.

핵심 지표

• 현재가: $8.19 (-3.99%)
• 시가총액: $0.34B
• 52주 최저~최고: $2.85 ~ $5.52
• 섹터: Healthcare
• 산업: Health Information Services
• 거래소: NASDAQ

소피아 제네틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

소피아 제네틱스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 8.08
• 순이익률: -1.00%
• 영업이익률: -0.80%

자주 묻는 질문